Medtronic PLC (MDT)
81.67
+0.75
(+0.93%)
USD |
NYSE |
May 03, 16:00
81.00
-0.67
(-0.82%)
After-Hours: 20:00
Medtronic Enterprise Value: 124.46B for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 124.46B |
| May 01, 2024 | 124.42B |
| April 30, 2024 | 123.55B |
| April 29, 2024 | 124.38B |
| April 26, 2024 | 122.89B |
| April 25, 2024 | 122.24B |
| April 24, 2024 | 123.74B |
| April 23, 2024 | 124.95B |
| April 22, 2024 | 123.99B |
| April 19, 2024 | 122.54B |
| April 18, 2024 | 122.16B |
| April 17, 2024 | 122.01B |
| April 16, 2024 | 122.24B |
| April 15, 2024 | 123.54B |
| April 12, 2024 | 123.41B |
| April 11, 2024 | 126.12B |
| April 10, 2024 | 126.33B |
| April 09, 2024 | 128.28B |
| April 08, 2024 | 127.10B |
| April 05, 2024 | 129.29B |
| April 04, 2024 | 128.44B |
| April 03, 2024 | 129.87B |
| April 02, 2024 | 130.14B |
| April 01, 2024 | 132.56B |
| March 28, 2024 | 132.73B |
| Date | Value |
|---|---|
| March 27, 2024 | 132.42B |
| March 26, 2024 | 128.15B |
| March 25, 2024 | 127.54B |
| March 22, 2024 | 127.32B |
| March 21, 2024 | 127.76B |
| March 20, 2024 | 128.60B |
| March 19, 2024 | 128.69B |
| March 18, 2024 | 128.09B |
| March 15, 2024 | 127.98B |
| March 14, 2024 | 129.06B |
| March 13, 2024 | 129.98B |
| March 12, 2024 | 130.86B |
| March 11, 2024 | 130.54B |
| March 08, 2024 | 130.05B |
| March 07, 2024 | 130.07B |
| March 06, 2024 | 130.60B |
| March 05, 2024 | 129.34B |
| March 04, 2024 | 129.95B |
| March 01, 2024 | 128.01B |
| February 29, 2024 | 127.70B |
| February 28, 2024 | 127.70B |
| February 27, 2024 | 128.33B |
| February 26, 2024 | 128.11B |
| February 23, 2024 | 130.76B |
| February 22, 2024 | 129.95B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
109.59B
Minimum
Oct 27 2023
197.40B
Maximum
Sep 08 2021
149.20B
Average
148.15B
Median
Jul 10 2019
Enterprise Value Benchmarks
| Abbott Laboratories | 191.41B |
| Boston Scientific Corp | 114.43B |
| Stryker Corp | 134.89B |
| Axonics Inc | 3.090B |
| Conmed Corp | 3.117B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.322B |
| Revenue (Quarterly) | 8.089B |
| Total Expenses (Quarterly) | 6.586B |
| EPS Diluted (Quarterly) | 0.99 |
| Gross Profit Margin (Quarterly) | 65.61% |
| Profit Margin (Quarterly) | 16.34% |
| Earnings Yield | 3.84% |
| Operating Earnings Yield | 5.64% |
| Normalized Earnings Yield | 4.172 |